Literature DB >> 23937439

The influence of innate and adaptive immune responses on atherosclerosis.

Joseph L Witztum1, Andrew H Lichtman.   

Abstract

Both the chronic development of atherosclerotic lesions and the acute changes in lesion phenotype that lead to clinical cardiovascular events are significantly influenced by the innate and adaptive immune responses to lipoprotein deposition and oxidation in the arterial wall. The rapid pace of discovery of mechanisms of immunologic recognition, effector functions, and regulation has significantly influenced the study of atherosclerosis, and our new knowledge is beginning to affect how we treat this ubiquitous disease. In this review, we discuss recent advances in our understanding of how innate and adaptive immunity contribute to atherosclerosis, as well as therapeutic opportunities that arise from this knowledge.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23937439      PMCID: PMC3988528          DOI: 10.1146/annurev-pathol-020712-163936

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  177 in total

Review 1.  Dendritic cells and their role in atherogenesis.

Authors:  Yuri V Bobryshev
Journal:  Lab Invest       Date:  2010-05-10       Impact factor: 5.662

2.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.

Authors:  M Freeman; Y Ekkel; L Rohrer; M Penman; N J Freedman; G M Chisolm; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Oxidized low-density lipoprotein and atherosclerosis.

Authors:  Daniel Steinberg; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

4.  Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice.

Authors:  Victoria L King; Stephen J Szilvassy; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

5.  Differential effects of regulatory T cells on the initiation and regression of atherosclerosis.

Authors:  A C Foks; V Frodermann; M ter Borg; K L L Habets; I Bot; Y Zhao; M van Eck; Th J C van Berkel; J Kuiper; G H M van Puijvelde
Journal:  Atherosclerosis       Date:  2011-05-05       Impact factor: 5.162

Review 6.  Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates?

Authors:  Paul M Ridker
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

Review 7.  Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.

Authors:  P Gounopoulos; E Merki; L F Hansen; S-H Choi; S Tsimikas
Journal:  Minerva Cardioangiol       Date:  2007-12       Impact factor: 1.347

8.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

9.  Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

Authors:  Joachim Listing; Anja Strangfeld; Jörn Kekow; Matthias Schneider; Andreas Kapelle; Siegfried Wassenberg; Angela Zink
Journal:  Arthritis Rheum       Date:  2008-03

10.  Participation of T lymphocytes in atherogenesis: sequential and quantitative observation of aortic lesions of rats with diet-induced hypercholesterolaemia using en face double immunostaining.

Authors:  S Haraoka; T Shimokama; T Watanabe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more
  101 in total

1.  Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.

Authors:  Young Sup Byun; Jun-Hee Lee; Benoit J Arsenault; Xiaohong Yang; Weihang Bao; David DeMicco; Rachel Laskey; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

2.  HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness.

Authors:  David Kuo; Jennifer Ding; Ian S Cohn; Fan Zhang; Kevin Wei; Deepak A Rao; Cristina Rozo; Upneet K Sokhi; Sara Shanaj; David J Oliver; Adriana P Echeverria; Edward F DiCarlo; Michael B Brenner; Vivian P Bykerk; Susan M Goodman; Soumya Raychaudhuri; Gunnar Rätsch; Lionel B Ivashkiv; Laura T Donlin
Journal:  Sci Transl Med       Date:  2019-05-08       Impact factor: 17.956

3.  The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Authors:  Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

Review 4.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

Review 5.  B Lymphocytes and Adipose Tissue Inflammation.

Authors:  Prasad Srikakulapu; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-05       Impact factor: 8.311

6.  Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.

Authors:  Ayelet Gonen; Lotte F Hansen; William W Turner; Erica N Montano; Xuchu Que; Apaїs Rafia; Meng-Yun Chou; Philipp Wiesner; Dimitrios Tsiantoulas; Maripat Corr; Michael S VanNieuwenhze; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum; Karsten Hartvigsen
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

Review 7.  Nucleic Acid Delivery for Endothelial Dysfunction in Cardiovascular Diseases.

Authors:  Dipti Deshpande; David R Janero; Victor Segura-Ibarra; Elvin Blanco; Mansoor M Amiji
Journal:  Methodist Debakey Cardiovasc J       Date:  2016-09

8.  Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling.

Authors:  Toshiaki Nakano; Shunsuke Katsuki; Mingxian Chen; Julius L Decano; Arda Halu; Lang Ho Lee; Diego V S Pestana; Angelo S T Kum; Rodrigo K Kuromoto; Whitney S Golden; Mario S Boff; Gabriel C Guimaraes; Hideyuki Higashi; Kevin J Kauffman; Takashi Maejima; Takehiro Suzuki; Hiroshi Iwata; Albert-László Barabási; Jon C Aster; Daniel G Anderson; Amitabh Sharma; Sasha A Singh; Elena Aikawa; Masanori Aikawa
Journal:  Circulation       Date:  2019-01-02       Impact factor: 29.690

Review 9.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

10.  Plasma phospholipid transfer protein (PLTP) modulates adaptive immune functions through alternation of T helper cell polarization.

Authors:  Catherine Desrumaux; Stéphanie Lemaire-Ewing; Nicolas Ogier; Akadiri Yessoufou; Arlette Hammann; Anabelle Sequeira-Le Grand; Valérie Deckert; Jean-Paul Pais de Barros; Naïg Le Guern; Julien Guy; Naim A Khan; Laurent Lagrost
Journal:  Cell Mol Immunol       Date:  2015-08-31       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.